WallStreetZen

NYSE: TEVA
Teva Pharmaceutical Industries Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for TEVA

Based on 1 analysts offering 12 month price targets for Teva Pharmaceutical Industries Ltd.
Min Forecast
$11.00+34.47%
Avg Forecast
$11.00+34.47%
Max Forecast
$11.00+34.47%

Should I buy or sell TEVA stock?

Based on 2 analysts offering ratings for Teva Pharmaceutical Industries Ltd.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
2 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

TEVA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Raymond James
Bottom 13%
13
HoldDowngradesN/AN/A2021-10-28
Wells Fargo
HoldMaintains$11.00+34.47%2021-07-29
UBS
Top 36%
65
HoldDowngrades$11.00+34.47%2021-05-04

1 of 1

Forecast return on equity

Is TEVA forecast to generate an efficient return?
Company
32.67%
Industry
91.05%
Market
37.5%
TEVA's Return on Equity is forecast to be high in 3 years (32.67%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is TEVA forecast to generate an efficient return on assets?
Company
7.15%
Industry
76.61%
TEVA is forecast to generate lower Return on Assets (7.15%) than the US Drug Manufacturers - Specialty & Generic industry average (76.61%)
Forecast

TEVA earnings per share forecast

What is TEVA's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$2.51+280.3%
Avg 2 year Forecast
$2.63+298.48%
Avg 3 year Forecast
$2.56+287.88%
TEVA's earnings are forecast to grow at an exceptional rate of 58.83% per year
Forecast

TEVA revenue forecast

What is TEVA's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$16.1B-1%
Avg 2 year Forecast
$16.3B+0.45%
Avg 3 year Forecast
$16.4B+1.03%
TEVA's revenue is forecast to grow at a rate of 0.34% per year, which is not exceptional
Forecast

TEVA earnings growth forecast

How is TEVA forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
58.83%
Industry
27.75%
Market
14.37%
TEVA's earnings are forecast to grow faster (58.83% per year) than the US Drug Manufacturers - Specialty & Generic industry average (27.75%)
Forecast
TEVA's earnings are forecast to grow faster (58.83% per year) than the US market average (14.37%)
Forecast
TEVA's earnings are forecast to grow faster (58.83% per year) than the risk-free savings rate (1.4%)
Forecast

TEVA revenue growth forecast

How is TEVA forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
0.34%
Industry
24.29%
Market
10.08%
TEVA's revenues are forecast to grow slower (0.34% per year) than the US Drug Manufacturers - Specialty & Generic industry average (24.29%)
Forecast
TEVA's revenues are forecast to grow slower (0.34% per year) than the US market average (10.08%)
Forecast

Teva Pharmaceutical Industries Ltd Stock Forecast FAQ

Is Teva Pharmaceutical Industries Ltd Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSE: TEVA) stock is to Hold TEVA stock.

Out of 2 analysts, 0 (0%) are recommending TEVA as a Strong Buy, 0 (0%) are recommending TEVA as a Buy, 2 (100%) are recommending TEVA as a Hold, 0 (0%) are recommending TEVA as a Sell, and 0 (0%) are recommending TEVA as a Strong Sell.

What is TEVA's earnings growth forecast for 2021-2023?

(NYSE: TEVA) Teva Pharmaceutical Industries Ltd's forecast annual earnings growth rate of 58.83% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 27.75%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 14.37%.

Teva Pharmaceutical Industries Ltd's earnings in 2021 is $726,000,000.On average, 4 Wall Street analysts forecast TEVA's earnings for 2021 to be $2,768,547,992, with the lowest TEVA earnings forecast at $2,691,337,490, and the highest TEVA earnings forecast at $2,823,698,350. On average, 4 Wall Street analysts forecast TEVA's earnings for 2022 to be $2,900,908,852, with the lowest TEVA earnings forecast at $2,757,517,920, and the highest TEVA earnings forecast at $2,989,149,425.

In 2023, TEVA is forecast to generate $2,823,698,350 in earnings, with the lowest earnings forecast at $2,823,698,350 and the highest earnings forecast at $2,823,698,350.

What is TEVA's revenue growth forecast for 2021-2023?

(NYSE: TEVA) Teva Pharmaceutical Industries Ltd's forecast annual revenue growth rate of 0.34% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 24.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Teva Pharmaceutical Industries Ltd's revenue in 2021 is $16,232,000,000.On average, 5 Wall Street analysts forecast TEVA's revenue for 2021 to be $17,724,936,931,237, with the lowest TEVA revenue forecast at $17,543,329,007,040, and the highest TEVA revenue forecast at $17,911,843,701,869. On average, 5 Wall Street analysts forecast TEVA's revenue for 2022 to be $17,985,308,391,286, with the lowest TEVA revenue forecast at $17,698,654,476,438, and the highest TEVA revenue forecast at $18,295,579,895,616.

In 2023, TEVA is forecast to generate $18,087,874,821,824 in revenue, with the lowest revenue forecast at $17,481,009,102,048 and the highest revenue forecast at $18,426,837,748,608.

What is TEVA's forecast return on assets (ROA) for 2021-2024?

(NYSE: TEVA) forecast ROA is 7.15%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 76.61%.

What is TEVA's Price Target?

According to 1 Wall Street analysts that have issued a 1 year TEVA price target, the average TEVA price target is $11.00, with the highest TEVA stock price forecast at $11.00 and the lowest TEVA stock price forecast at $11.00.

On average, Wall Street analysts predict that Teva Pharmaceutical Industries Ltd's share price could stay at $11.00 by Oct 28, 2022. The average Teva Pharmaceutical Industries Ltd stock price prediction forecasts a potential downside of N/A from the current TEVA share price of $8.18.

What is TEVA's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: TEVA) Teva Pharmaceutical Industries Ltd's current Earnings Per Share (EPS) is $0.66. On average, analysts forecast that TEVA's EPS will be $2.51 for 2021, with the lowest EPS forecast at $2.44, and the highest EPS forecast at $2.56. On average, analysts forecast that TEVA's EPS will be $2.63 for 2022, with the lowest EPS forecast at $2.50, and the highest EPS forecast at $2.71. In 2023, TEVA's EPS is forecast to hit $2.56 (min: $2.56, max: $2.56).

What is TEVA's forecast return on equity (ROE) for 2021-2024?

(NYSE: TEVA) forecast ROE is 32.67%, which is considered strong.
©2021 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.